Press Release
Category Added in a WPeMatico Campaign
-
Finance firms face surging AI risks as conduct incidents average USD 14 million
The share of C-suite executives identifying AI-related conduct risks as a top material risk has jumped from 16% over the…
Read More » -
IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies
Patients in the IMAAVY 30 mg/kg treatment groupa achieved statistically significant durable hemoglobin responseb, with mean hemoglobin improvement of at…
Read More » -
Business Wire3 weeks ago
Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions
– Data from pivotal studies of CASGEVY in children ages 5–11 with severe sickle cell disease or transfusion-dependent beta thalassemia…
Read More » -
Business Wire3 weeks ago
ACI Worldwide Powers Next-Generation PSP Expansion in Africa with Kwik Payments Go-Live
Kwik Payments utilizes ACI’s Payments Orchestration Platform to help merchants reduce checkout friction and drive conversion uplifts of more than…
Read More » -
Business Wire3 weeks ago
Oasis Welcomes ISS & Glass Lewis Support for Removal of KADOKAWA CEO Natsuno (Securities Code: 9468 JT)
*Leading proxy advisors ISS and Glass Lewis recommend shareholders vote AGAINST the re-election of CEO Takeshi Natsuno and FOR Oasis’s…
Read More » -
Durham Constabulary Selects NicheRMS365 to Power Smarter, Safer, and More Connected Policing
DURHAM, England, June 11, 2026 /PRNewswire/ — Durham Constabulary has selected NicheRMS365: the next-generation technology platform that centralizes operational data,…
Read More » -
Roche’s VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies
Used as a predictive biomarker, the first-of-its-kind VENTANA MMR RxDx Panel helps identify cancer patients eligible for treatment with certain…
Read More » -
Business Wire3 weeks ago
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
Filing acceptance is based on the Phase III Alliance ATOMIC study showing Tecentriq plus chemotherapy reduced recurrence or death risk…
Read More » -
Business Wire3 weeks ago
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
Filing acceptance is based on the Phase III Alliance ATOMIC study showing Tecentriq plus chemotherapy reduced recurrence or death risk…
Read More » -
Business Wire3 weeks ago
BW LPG Limited – Ex-dividend on the Oslo Stock Exchange Today
SINGAPORE–(BUSINESS WIRE)–With reference to the press release dated 2 June 2026 by BW LPG Limited (“BW LPG” or the “Company”,…
Read More »